3. PAC
Generic
KOL/HOD
MD/Technical head
Nurses
Technicians
Paharmacist/Storepersons
CME
Influencer
In clinic discussion
Collaborative work
Involving distributor
Referral Hospital
Queries & solution
Policy related with Pdt
Policy related with Budget
Co./Product registration
Indent generation
Quantity
Price
Time
Order generation
Stock Liquidation
Payment recovery
Ensuring completion of activity
Competitors activity
Shortlisting products
Rate approvals
Rate Contract/LP
Description
Budget allocation for medicine/surgical/hosp equipment etc
Director/Dean/HOD/Tech.Head/Pharmacist/Stores
Onco/Med/Nephro/Derma etc
No of patients visiting OPD/IPD
Only HOD of the oncology department have the authority o
indend of onco product.
Proprietary product that don't have competitor
Insulin Regular/Atorvastatin/Glimepiride/Erythro etc
Ex Govt policy for covid/ emergency procurement
Inhouse/outside CME on latest updates about the product d
Customer making decesion to include the product in hospita
Inclinic discussion with sr managers
Collaborative work with medical/marketing/trade team
If the customer want to deal with selective distributor
Patient taking treatment from referral hospital then trackin
Solving customer queries regarding product/service etc
f KAM in pharma sector
Monitoring activities and impact of customer engagement o
the procurement process
Special budget allocation for perticular disease
5. Description
rgical/hosp equipment etc
harmacist/Stores
ment have the authority of inclusion/generating
ve competitor
epiride/Erythro etc
cy procurement
dates about the product development
ude the product in hospital because of influenced by other person/doctor recommendatoin
rs
marketing/trade team
selective distributor
erral hospital then tracking the file, prescribers
g product/service etc
of customer engagement on procurement, Tracking all
cular disease